Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.14M | 6,452,398 | 6.87% | 93.13% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $18.26M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $2.30M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| IMA | IMAGENEBIO INC | $32.17M | 4,021,508 | 75.44% | 24.56% | Net Buying | Net Selling | ||
| ACXP | ACURX PHARMACEUTICALS INC | $10.32M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $48.81M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| ATYR | ATYR PHARMA INC | $85.98M | 89,004,436 | 74.54% | 17.28% | Net Buying | Net Buying | ||
| FGEN | FIBROGEN INC | $43.80M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| SGMO | SANGAMO THERAPEUTICS INC | $190.98M | 301,709,485 | 16.98% | 10.65% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $61.54M | 99,264,526 | 0.38% | 23.86% | Net Buying | Net Buying | ||
| NRXP | NRX PHARMACEUTICALS INC | $62.07M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $33.92M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| FEMY | FEMASYS INC | $17.24M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| GRI | GRI BIO INC | $5.16M | 2,515,305 | 0.71% | 99.29% | ||||
| UNCY | UNICYCIVE THERAPEUTICS INC | $90.60M | 17,661,698 | 29.13% | 25.91% | ||||
| TVRD | TVARDI THERAPEUTICS INC | $46.61M | 9,377,433 | 5.93% | 94.07% | Net Selling | |||
| CING | CINGULATE INC | $20.89M | 5,412,523 | 3.75% | 96.25% | ||||
| LSTA | LISATA THERAPEUTICS INC | $20.21M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| SKYE | SKYE BIOSCIENCE INC | $47.72M | 30,988,420 | 2.80% | 97.20% | Net Selling | Net Selling | ||
| INTS | INTENSITY THERAPEUTICS INC | $11.20M | 47,057,727 | 4.20% | 4.44% | Net Buying | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $25.41M | 23,858,301 | 10.74% | 60.23% | ||||
| IMUX | IMMUNIC INC | $73.59M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| MDCX | MEDICUS PHARMA LTD | $48.10M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| NOTE | FISCALNOTE HOLDINGS INC | $62.71M | 14,349,995 | 32.26% | 67.74% | Net Selling | Net Selling | ||
| JSPR | JASPER THERAPEUTICS INC | $38.52M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| PASG | PASSAGE BIO INC | $22.71M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| MBRX | MOLECULIN BIOTECH INC | $14.72M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| PMN | PROMIS NEUROSCIENCES INC | $22.28M | 51,806,497 | 16.36% | 61.54% | Net Buying | Net Buying | ||
| VNRX | VOLITIONRX LTD | $47.34M | 107,595,421 | 22.29% | 35.41% | Net Buying | Net Buying | ||
| MTVA | METAVIA INC | $23.71M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $86.88M | 59,508,518 | 48.27% | 28.91% | Net Buying | |||
| MYO | MYOMO INC | $41.96M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.29M | 2,611,788 | 0.26% | 99.74% | ||||
| ACET | ADICET BIO INC | $73.61M | 82,709,625 | 62.39% | 20.18% | Net Buying | Net Buying | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $266.26M | 221,881,029 | 70.15% | 29.85% | Net Selling | Net Selling | ||
| PHIO | PHIO PHARMACEUTICALS CORP | $12.14M | 5,726,750 | 0.16% | 99.84% | Net Buying | Net Selling | ||
| ANVS | ANNOVIS BIO INC | $39.95M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying | ||
| CTSO | CYTOSORBENTS CORP | $53.22M | 62,610,376 | 26.26% | 45.19% | Net Buying | |||
| TIL | INSTIL BIO INC | $130.96M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| RNXT | RENOVORX INC | $43.24M | 36,645,884 | 24.00% | 11.42% | Net Buying | Net Buying | ||
| ATOS | ATOSSA THERAPEUTICS INC | $120.39M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $13.32M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| HBIO | HARVARD BIOSCIENCE INC | $18.17M | 44,531,198 | 37.21% | 62.79% | Net Selling | Net Selling |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.